This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Accelerating the development of COVID vaccines and therapeutics
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Aptar Pharma expert Q&A on digital health and connected drug delivery
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions
Aptar Pharma discusses Article 117 of the Medical Device Regulations
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Drug Delivery Systems & Services for Lifecycle Management of Crisis Medications ...
Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions
